Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Deutsche AIDS Gesellschaft e.V. | UNKNOWN |
Standard therapy for HIV-related Hodgkin lymphoma (HIV-HL) has not been defined. This trial was initiated to investigate a risk adapted treatment strategy in patients (pts) with HIV-HL as established in HIV-negative patients with HL.
Treatment schedule:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Doxorubicin | Drug | The four-drug ABVD chemotherapy regimen and the seven-drug BEACOPP-baseline chemotherapy regimen contain doxorubicin.
| ||
| Bleomycin | Drug | The four-drug ABVD chemotherapy regimen and the seven-drug BEACOPP-baseline chemotherapy regimen contain bleomycin.
| ||
| Vinblastine | Drug | The four-drug ABVD chemotherapy regimen contains vinblastine
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients with World Health Organization (WHO) grade 3 and grade 4 toxicity | 30 days after termination of chemotherapy or radiotherapy | |
| Treatment related mortality | 30 days after termination of chemotherapy or radiotherapy |
| Measure | Description | Time Frame |
|---|---|---|
| Overall Survival | 12 months and 24 months after termination of chemotherapy or radiotherapy | |
| Progression-free survival | 12 months and 24 months after termination of chemotherapy or radiotherapy | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Marcus Hentrich, MD | Contact | 0049 89 6210 2663 | marcus.hentrich@klinikum-muenchen.de |
| Name | Affiliation | Role |
|---|---|---|
| Marcus Hentrich, MD | Harlaching Hospital, Academic Teaching Hospital of the University of Munich, Department of Hematology, Oncology and Palliative Care | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Vivantes Auguste Victoria Klinikum | Recruiting | Berlin | 12157 | Germany |
Not provided
| ID | Term |
|---|---|
| D004317 | Doxorubicin |
| D001761 | Bleomycin |
| D014747 | Vinblastine |
| D003606 | Dacarbazine |
| D005047 | Etoposide |
| D003520 | Cyclophosphamide |
| D014750 | Vincristine |
| D011344 | Procarbazine |
| D011241 | Prednisone |
| ID | Term |
|---|---|
| D003630 | Daunorubicin |
| D018943 | Anthracyclines |
| D009279 | Naphthacenes |
| D011084 | Polycyclic Aromatic Hydrocarbons |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Dacarbazine | Drug | The four-drug ABVD chemotherapy regimen contains dacarbazine
|
| Etoposide | Drug | The seven-drug BEACOPP-baseline chemotherapy regimen contains etoposide.
|
| Cyclophosphamide | Drug | The seven-drug BEACOPP-baseline chemotherapy regimen contains cyclophosphamide.
|
| Vincristine | Drug | The seven-drug BEACOPP-baseline chemotherapy regimen contains vincristine.
|
| Procarbazine | Drug | The seven-drug BEACOPP-baseline chemotherapy regimen contains procarbazine.
|
| Prednisone | Drug | The seven-drug BEACOPP-baseline chemotherapy regimen contains prednisone.
|
| Complete remission rate |
| 30 days and 90 days after termination of chemotherapy or radiotherapy |
| Ärzteforum Seestrasse | Recruiting | Berlin | 13347 | Germany |
|
| Universiy of Bonn | Recruiting | Bonn | 53127 | Germany |
|
| University of Cologne | Recruiting | Cologne | 50924 | Germany |
|
| University of Frankfurt | Recruiting | Frankfurt | 60590 | Germany |
|
| Asklepios Klinikum St. Georg | Recruiting | Hamburg | 20099 | Germany |
|
| Infektionsmedizinisches Zentrum Hamburg | Recruiting | Hamburg | 20146 | Germany |
|
| Harlaching Hospital | Recruiting | Munich | 81545 | Germany |
|
| D006841 |
| Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |
| D011083 | Polycyclic Compounds |
| D000617 | Aminoglycosides |
| D006027 | Glycosides |
| D002241 | Carbohydrates |
| D006020 | Glycopeptides |
| D006001 | Glycoconjugates |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |
| D014748 | Vinca Alkaloids |
| D046948 | Secologanin Tryptamine Alkaloids |
| D026121 | Indole Alkaloids |
| D000470 | Alkaloids |
| D006571 | Heterocyclic Compounds |
| D007211 | Indoles |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D054836 | Indolizidines |
| D007212 | Indolizines |
| D014226 | Triazenes |
| D007093 | Imidazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D011034 | Podophyllotoxin |
| D013764 | Tetrahydronaphthalenes |
| D009281 | Naphthalenes |
| D005960 | Glucosides |
| D010752 | Phosphoramide Mustards |
| D009588 | Nitrogen Mustard Compounds |
| D009150 | Mustard Compounds |
| D006846 | Hydrocarbons, Halogenated |
| D063088 | Phosphoramides |
| D009943 | Organophosphorus Compounds |
| D001549 | Benzamides |
| D000577 | Amides |
| D001565 | Benzoates |
| D000146 | Acids, Carbocyclic |
| D002264 | Carboxylic Acids |
| D001555 | Benzene Derivatives |
| D011244 | Pregnadienediols |
| D011245 | Pregnadienes |
| D011278 | Pregnanes |
| D013256 | Steroids |
| D000072473 | Fused-Ring Compounds |